Disis ML - Search Results

1

VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC.

Lu H, Dietsch GN, Matthews MA, Yang Y, Ghanekar S, Inokuma M, Suni M, Maino VC, Henderson KE, Howbert JJ, Disis ML, Hershberg RM. Lu H, et al. Among authors: disis ml. Clin Cancer Res. 2012 Jan 15;18(2):499-509. doi: 10.1158/1078-0432.CCR-11-1625. Epub 2011 Nov 29. Clin Cancer Res. 2012. PMID: 22128302

2

Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.

Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR, Cheever MA. Bernhard H, et al. Among authors: disis ml. Cancer Res. 1995 Mar 1;55(5):1099-104. Cancer Res. 1995. PMID: 7532543

3

Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity.

Knutson KL, Schiffman K, Cheever MA, Disis ML. Knutson KL, et al. Among authors: disis ml. Clin Cancer Res. 2002 May;8(5):1014-8. Clin Cancer Res. 2002. PMID: 12006513 Clinical Trial.

4

Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles.

Salazar LG, Fikes J, Southwood S, Ishioka G, Knutson KL, Gooley TA, Schiffman K, Disis ML. Salazar LG, et al. Among authors: disis ml. Clin Cancer Res. 2003 Nov 15;9(15):5559-65. Clin Cancer Res. 2003. PMID: 14654536 Clinical Trial.

5

Neu antigen-negative variants can be generated after neu-specific antibody therapy in neu transgenic mice.

Knutson KL, Almand B, Dang Y, Disis ML. Knutson KL, et al. Among authors: disis ml. Cancer Res. 2004 Feb 1;64(3):1146-51. doi: 10.1158/0008-5472.can-03-0173. Cancer Res. 2004. PMID: 14871850

6

Maximizing the retention of antigen specific lymphocyte function after cryopreservation.

Disis ML, dela Rosa C, Goodell V, Kuan LY, Chang JC, Kuus-Reichel K, Clay TM, Kim Lyerly H, Bhatia S, Ghanekar SA, Maino VC, Maecker HT. Disis ML, et al. J Immunol Methods. 2006 Jan 20;308(1-2):13-8. doi: 10.1016/j.jim.2005.09.011. Epub 2005 Oct 21. J Immunol Methods. 2006. PMID: 16337957

7

The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens.

Lu H, Knutson KL, Gad E, Disis ML. Lu H, et al. Among authors: disis ml. Cancer Res. 2006 Oct 1;66(19):9754-61. doi: 10.1158/0008-5472.CAN-06-1083. Cancer Res. 2006. PMID: 17018635

8

Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer.

Lu H, Goodell V, Disis ML. Lu H, et al. Among authors: disis ml. Expert Opin Ther Targets. 2007 Feb;11(2):235-44. doi: 10.1517/14728222.11.2.235. Expert Opin Ther Targets. 2007. PMID: 17227237 Review.

9

Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.

Dang Y, Knutson KL, Goodell V, dela Rosa C, Salazar LG, Higgins D, Childs J, Disis ML. Dang Y, et al. Among authors: disis ml. Clin Cancer Res. 2007 Mar 15;13(6):1883-91. doi: 10.1158/1078-0432.CCR-06-2083. Clin Cancer Res. 2007. PMID: 17363545

10

Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors.

Ghanekar SA, Bhatia S, Ruitenberg JJ, DeLa Rosa C, Disis ML, Maino VC, Maecker HT, Waters CA. Ghanekar SA, et al. Among authors: disis ml. J Immune Based Ther Vaccines. 2007 May 3;5:7. doi: 10.1186/1476-8518-5-7. J Immune Based Ther Vaccines. 2007. PMID: 17477875 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters